Eli Lilly and Co
Change company Symbol lookup
Select an option...
LLY Eli Lilly and Co
INTC Intel Corp
DVN Devon Energy Corp
CCL Carnival Corp
OKE ONEOK Inc
BMY Bristol-Myers Squibb Co
KO Coca-Cola Co
DOW Dow Inc
CTVA Corteva Inc
COP Conocophillips
Go

Health Care : Pharmaceuticals | Large Cap Growth
Company profile

Eli Lilly and Company is engaged in a drug manufacturing business. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Trajenta, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant, Baricitinib, and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups to service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in about 120 countries.

Closing Price
$365.25
Day's Change
3.53 (0.98%)
Bid
--
Ask
--
B/A Size
--
Day's High
365.83
Day's Low
361.55
Volume
(Light)
Volume:
1,039,094

10-day average volume:
3,176,973
1,039,094

Barclays Hires Marc Giannoni as Chief US Economist

8:00 am ET September 6, 2022 (BusinessWire) Print

Barclays has appointed Marc Giannoni as Managing Director and Chief US Economist for Research. Giannoni is based in New York and reports to Christian Keller, Head of Economics Research.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220906005191/en/

Giannoni joined Barclays this month from the Federal Reserve Bank of Dallas, where he served as Head of the Research and Statistics Departments since 2017. Prior to the Dallas Fed, Giannoni worked for the Federal Reserve Bank of New York for more than eight years, focusing on macroeconomic and monetary topics. He also previously taught finance and economics as a faculty member at Columbia Business School.

"We are delighted to welcome Marc to Barclays and our global Research team," Keller said. "His thought leadership and deep expertise in monetary policy, macroeconomics, energy, and trade will be a core differentiator as we continue to help institutional clients navigate this uncertain time in the US and global economy."

Giannoni is also a research affiliate for the Center for Economic Policy Research and a researcher for the Center for Interuniversity Research and Analysis in Organizations. Giannoni was also previously a research fellow for the National Bureau of Economic Research.

He holds a PhD in Economics from Princeton University.

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customer and client, and geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services across the Barclays Group. For further information about Barclays, please visit our website home.barclays.

About Barclays Corporate and Investment Bank

Barclays is a consumer and wholesale bank, supporting individuals and small businesses through our consumer banking services, and larger businesses and institutions through our corporate and investment banking services. Our Corporate and Investment Bank is comprised of the Investment Banking, International Corporate Banking, Global Markets and Research businesses; it provides money managers, financial institutions, governments, supranational organisations and corporate clients with services and advice for their funding, financing, strategic and risk management needs. For further information about Barclays Corporate and Investment Bank, please visit our website www.cib.barclays.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005191/en/

SOURCE: Barclays

Matt Scully
212-526-7844
matthew.scully@Barclays.com
comtex tracking

COMTEX_413839963/1006/2022-09-06T08:00:03

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.